| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |